Study of XL999 in Patients With Metastatic Renal Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lynne A. Bui, MD
Exelixis
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Hematology/oncology
Los Angeles, California, United States
- Stanford Cancer Center
Palo Alto, California, United States
- Integrated Community Oncology Network
Jacksonville, Florida, United States
- University of Chicago
Chicago, Illinois, United States
- Joliet Oncology-Hematology Associates, Ltd
Joliet, Illinois, United States
- Division of Hematology/oncology, Indiana University Cancer Center
Indianapolis, Indiana, United States
- the Cleveland Clinic Foundation Taussig Cancer Center
Cleveland, Ohio, United States
- Center for Oncology Research and Treatment, Pa
Dallas, Texas, United States
- the Center for Cancer and Blood Disorders
Fort Worth, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2005
- Primary completion
- 28 Feb 2007
- Completion
- 30 Jun 2007
- Last update posted
- 19 Feb 2010
- Registered enrollment
- 11
- Registry id
- NCT00277316
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.